New and Noteworthy

Showing 9 of 0 results

• The future of ctDNA in cancer care: real-world signals, real clinical impact
  • Real-world evidence
  • Article
  • Breast cancer
• From Obligation to Opportunity: Accelerating Safety Evidence Using Digital and Pragmatic Solutions
  • Research
  • Real-world evidence
  • Prospective study
  • Post marketing requirements
• Data You Can Trust: Setting the Bar for ML/LLM-Extracted RWD
  • Real-world evidence
  • Machine learning
  • Webinar
  • Artificial intelligence
• Can You Trust Real-World Data Extracted by a Large Language Model (LLM)?
  • Real-world evidence
  • Machine learning
  • Article
  • Artificial intelligence
• Key considerations for assessing real-world comparative effectiveness in the context of the Drug Price Negotiation program: A case study of pembrolizumab

  PharmaEconomics

  • Comparative effectiveness
  • Non-small cell lung cancer
• Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practice

  ESMO Open

  • Publication summary
  • Publications
  • Comparative effectiveness
  • Metastatic breast cancer
  • Breast cancer
• Real-World Evidence for Oncology Innovation in Europe
  • Real-world evidence
  • Webinar
• Real-world treatment patterns in ES-SCLC highlight continued unmet medical need in the era of new therapies: ESSENCE Study

  World Conference on Lung Cancer

  • Publication summary
  • Publications
  • Treatment patterns
  • Small cell lung cancer
• Real-world treatment patterns and clinical outcomes in patients with metastatic neuroendocrine neoplasms of the lung (NEN-L)

  World Conference on Lung Cancer

  • Publication summary
  • Publications
  • Treatment patterns
  • Non-small cell lung cancer